At Patient Worthy, we aim to publish the realities of #RareDisease. Your voice is integral to achieving that goal.
Would you like to contribute and share your story? You can submit here - https://t.co/XYjEYjybeo - OR let us know if you'd like to work with a writer.
Thanks to recent advances in 3D modeling and spatial mapping, scientists are learning more than ever about how liver diseases like MASH affect liver cells, including areas of inflammation and metabolic changes as fibrosis worsens. Read more here:
https://t.co/y4tY2Ctv88
Early findings from a Phase I/II clinical trial suggest that a novel medication, selcodebart, may help reduce dependence upon blood transfusions in patients living with myelofibrosis-associated anemia. Read more here, or at https://t.co/2TpfNrZV1i!
https://t.co/AfnYBiyDfr
Early findings from a Phase I/II clinical trial suggest that a novel medication, selcodebart, may help reduce dependence upon blood transfusions in patients living with myelofibrosis-associated anemia. Read more here, or at https://t.co/2TpfNrZV1i!
https://t.co/AfnYBiyDfr
Singapore has officially approved Wegovy for another indication: the treatment of moderate-to-severe, noncirrhotic MASH (metabolic dysfunction-associated steatohepatitis). Read more here, or use the link in our bio!
https://t.co/lsJDbPOUgu
The future for recovery and repair of PNIs (peripheral nerve injuries) and SCIs (spinal cord injuries) is looking brighter than ever, as advances in stem cell research continue to open promising new avenues. Read more here, or click the link in our bio!
https://t.co/zfhE4bwDa2
We're honored to bring you Stephen's story of living with esophageal cancer, and how finding support through his community and sharing his story have helped him stay positive and find meaning. Read here:
https://t.co/Cn2i6srk87
#PatientWorthy#ShareYourStory#Cancer
We're honored to share Nick's story as an MS patient, and how his journey led him to create "ms life," which helps to support other people living with the condition. Read here:
https://t.co/XGiST8G7BG
Today our spotlight is on Christoph Muth, a German man currently residing in Thailand. Christoph is living with a rare combination of progressive neurological and sensory disorders, and hopes to find help at a rare-disease research facility. Read here:
https://t.co/tWN97SQPuY
We're honored to share this interview between Dr. Thaker and Kate, an ovarian cancer patient, as they discuss life with ovarian cancer and treatments. Read here:
https://t.co/cDPQ4HtaXr
We're honored to share another article from our friend Tom Seaman, who's back with advice about living with dystonia and anxiety. Read here:
https://t.co/uoNzDXgHDY
Finding Balance: David and Charice's Journey with Parkinson's Disease https://t.co/rHk0cntACl Read about David's diagnosis and both his and Charice's navigation through life with Parkinson's disease now at https://t.co/pYPVOJiweA
#PatientWorthy#Parkinson'sDisease #PatientStory
We're honored and thrilled to bring you this article by Dr. Avishek Kumar, discussing breaking news on how pancreatic cancer treatment has potentially been changed forever. Read here:
https://t.co/pVCWyNWD22
#PatientWorthy#Cancer#PancreaticCancer#ShareYourStory
Caplyta Gains FDA Approval for Schizophrenia Relapse Prevention with Significant Clinical Benefit https://t.co/3Xb7tZDgQJ Read now at https://t.co/pYPVOJiweA
#PatientWorthy#Schizophrenia#Caplyta
Votoplam Advances to Phase 3: Novartis and PTC Chart Measured Path for Huntington's Disease Treatment https://t.co/IRPScfMc5r Read now at https://t.co/pYPVOJiweA
#PatientWorthy#Votoplam#Novartis#PTC#Huntington'sDisease
RNA-Targeting CRISPR: A Breakthrough Approach to Inhibiting Hepatitis E Virus https://t.co/XJ6swbahA3 Read now at https://t.co/pYPVOJiweA
#CRISPR#PatientWorthy#HepatitisE
Breaking Through: UniQure's Huntington's Gene Therapy Pursues UK Approval After US Setback https://t.co/gn3IvtJSJV Read now at https://t.co/pYPVOJiweA
#PatientWorthy#UniQure#Huntington'sDisease
Merck and Exelixis Team Up to Transform Treatment for High-Risk Colorectal Cancer Patients https://t.co/i9hmhCBRQD Read now at https://t.co/pYPVOJiweA
#PatientWorthy#ColorectalCancer#Keytruda